Location: Tarrytown, NY
CIK: 0000872589 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 1, 2025
Total Value: $1.485B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 4,444,445 | $1.449B | 97.6% | $262.99 | +5.2% | Common Stock | 02043Q107 |
| NTLA | Intellia Therapeutics, Inc. | 3,702,995 | $34.73M | 2.3% | $15.61 | -47.4% | Common Stock | 45826J105 |
| — | Adicet Bio, Inc. | 968,183 | $591K | 0.0% | $0.96 | — | Common Stock | 007002108 |
| — | Adverum Biotechnologies, Inc. | 180,909 | $389K | 0.0% | $4.67 | — | Common Stock | 00773U207 |